Pharmacological inhibition of NF-κB prolongs lifespan of Drosophila melanogaster

Aging

Volumn 3, Issue 4, 2011, Pages 391-394

  Moskalev, Alexey ^a   Shaposhnikov, Mikhail ^a  

^a INSTITUTE OF BIOLOGY   (Russian Federation)

Author keywords

Aging; Anti aging agents; Drosophila melanogaster; Lifespan; NF B

Indexed keywords

ANTIOXIDANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; THIOCARBAMIC ACID DERIVATIVE;

ANIMAL; ARTICLE; DROSOPHILA MELANOGASTER; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; LONGEVITY; MALE; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; DROSOPHILA MELANOGASTER; FEMALE; LONGEVITY; MALE; NF-KAPPA B; PYRROLIDINES; THIOCARBAMATES;

EID: 80052102573     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100314     Document Type: Article

References (23)

1. McCarroll SA, Murphy CT, Zou S, Pletcher SD, Chin CS, Jan YN, Kenyon C, Bargmann CI, Li H. Comparing genomic expression patterns across species identifies shared transcriptional profile in aging. Nat Genet. 2004; 36: 197-204.
2. Papa S, Zazzeroni F, Pham CG, Bubici C, Franzoso G. Linking JNK signaling to NF-κB: a key to survival. J Cell Sci. 2004; 117: 5197-5208.
3. Chen LF, Greene WC. Shaping the nuclear action of NF-κB. Nat Rev Mol Cell Biol. 2004; 5: 392-401.
4. Kriete A, Mayo KL. Atypical pathways of NF-κB activation and aging. Exp Gerontol. 2009; 44: 250-255.
5. Baker RG, Hayden MS, Ghosh S. NF-κB, inflammation, and metabolic disease. Cell Metab. 2011; 13: 11-22.
6. Salminen A, Kaarniranta K. NF-κB signaling in the aging process. J Clin Immunol. 2009; 29: 397-405.
7. Govind S. Control of development and immunity by Rel transcription factors in Drosophila. Oncogene. 1999; 18: 6875-6887.
8. Gross I, Georgel P, Oertel-Buchheit P, Schnarr M, Reichhart JM. Dorsal-B, a splice variant of the Drosophila factor Dorsal, is a novel Rel/NF-κB transcriptional activator. Gene. 1999; 228: 233-242.
9. Hoffmann JA. The immune response of Drosophila. Nature. 2003; 426: 33-38.
10. Donato AJ, Black AD, Jablonski KL, Gano LB, Seals DR. Aging is associated with greater nuclear NFκB, reduced IαBa, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans. Aging Cell. 2008; 7: 805-812.
11. Wiggins JE, Patel SR, Shedden KA, Goyal M, Wharram BL, Martini S, Kretzler M, Wiggins RC. NFκB promotes inflammation, coagulation, and fibrosis in the aging glomerulus. J Am Soc Nephrol. 2010; 21: 587-597.
12. Gareus R, Kotsaki E, Xanthoulea S, van der Made I, Gijbels MJ, Kardakaris R, Polykratis A, Kollias G, de Winther MP, Pasparakis M. Endothelial cell-specific NF-κB inhibition protects mice from atherosclerosis. Cell Metab. 2008; 8: 372-383.
13. Adler AS, Kawahara TL, Segal E, Chang HY. Reversal of aging by NFκB blockade. Cell Cycle. 2008; 7: 556-559.
14. Adler AS, Sinha S, Kawahara TL, Zhang JY, Segal E, Chang HY. Motif module map reveals enforcement of aging by continual NF-κB activity. Genes Dev. 2007; 21: 3244-3257.
15. Kawahara TL, Michishita E, Adler AS, Damian M, Berber E, Lin M, McCord RA, Ongaigui KC, Boxer LD, Chang HY, Chua KF. SIRT6 links histone H3 lysine 9 deacetylation to NF-κBdependent gene expression and organismal life span. Cell. 2009; 136: 62-74.
16. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med. 1992; 175: 1181-1194.
17. Ashburner M. (1989). Drosophila: A laboratory manual (Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory).
18. Finch CE. (1990). Longevity, senescence, and the genome (Chicago: University of Chicago Press).
19. Fleming TR, O'Fallon JR, O'Brien PC, Harrington DP. Modified Kolmogorov-Smirnov test procedures with application to arbitrarily right-censored data. Biometrics. 1980; 36: 607-625.
20. Breslow N. A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika. 1970; 57: 579-594.
21. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966; 50: 163-170.
22. Wang C, Li Q, Redden DT, Weindruch R, Allison DB. Statistical methods for testing effects on "maximum lifespan". Mech Ageing Dev. 2004; 125: 629-632.
23. Pletcher SD. Model fitting and hypothesis testing for agespecific mortality data. J Evol Biol. 1999; 12: 430-439.